- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Streptococcus Pneumoniae Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Streptococcus Pneumoniae Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Children under 2 Years of Age accounting for % of the Streptococcus Pneumoniae Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 7 -Valent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Streptococcus Pneumoniae Vaccine include Pfizer, Sanofi, GSK, Merck, and Eli Lilly, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Streptococcus Pneumoniae Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
7 -Valent
10 -Valent
13 -Valent
15 -Valent
23 -Valent
Other
Market segment by Application can be divided into
Children under 2 Years of Age
Adults over 65 Years of Age
Addicted Smokers Between the Ages of 19 and 64
Other
The key market players for global Streptococcus Pneumoniae Vaccine market are listed below:
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Streptococcus Pneumoniae Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Streptococcus Pneumoniae Vaccine, with price, sales, revenue and global market share of Streptococcus Pneumoniae Vaccine from 2019 to 2022.
Chapter 3, the Streptococcus Pneumoniae Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Streptococcus Pneumoniae Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Streptococcus Pneumoniae Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Streptococcus Pneumoniae Vaccine.
Chapter 13, 14, and 15, to describe Streptococcus Pneumoniae Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Streptococcus Pneumoniae Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Streptococcus Pneumoniae Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 7 -Valent
1.2.3 10 -Valent
1.2.4 13 -Valent
1.2.5 15 -Valent
1.2.6 23 -Valent
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Streptococcus Pneumoniae Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Children under 2 Years of Age
1.3.3 Adults over 65 Years of Age
1.3.4 Addicted Smokers Between the Ages of 19 and 64
1.3.5 Other
1.4 Global Streptococcus Pneumoniae Vaccine Market Size & Forecast
1.4.1 Global Streptococcus Pneumoniae Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Streptococcus Pneumoniae Vaccine Sales in Volume (2017-2028)
1.4.3 Global Streptococcus Pneumoniae Vaccine Price (2017-2028)
1.5 Global Streptococcus Pneumoniae Vaccine Production Capacity Analysis
1.5.1 Global Streptococcus Pneumoniae Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Streptococcus Pneumoniae Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Streptococcus Pneumoniae Vaccine Market Drivers
1.6.2 Streptococcus Pneumoniae Vaccine Market Restraints
1.6.3 Streptococcus Pneumoniae Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Streptococcus Pneumoniae Vaccine Product and Services
2.1.4 Pfizer Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Streptococcus Pneumoniae Vaccine Product and Services
2.2.4 Sanofi Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Streptococcus Pneumoniae Vaccine Product and Services
2.3.4 GSK Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Streptococcus Pneumoniae Vaccine Product and Services
2.4.4 Merck Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Product and Services
2.5.4 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Product and Services
2.6.4 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Abera
2.7.1 Abera Details
2.7.2 Abera Major Business
2.7.3 Abera Streptococcus Pneumoniae Vaccine Product and Services
2.7.4 Abera Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 S K Chemicals
2.8.1 S K Chemicals Details
2.8.2 S K Chemicals Major Business
2.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Product and Services
2.8.4 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Beijing Minhai Biotechnology
2.9.1 Beijing Minhai Biotechnology Details
2.9.2 Beijing Minhai Biotechnology Major Business
2.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product and Services
2.9.4 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Baxter
2.10.1 Baxter Details
2.10.2 Baxter Major Business
2.10.3 Baxter Streptococcus Pneumoniae Vaccine Product and Services
2.10.4 Baxter Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Biken
2.11.1 Biken Details
2.11.2 Biken Major Business
2.11.3 Biken Streptococcus Pneumoniae Vaccine Product and Services
2.11.4 Biken Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Celgene Corporation
2.12.1 Celgene Corporation Details
2.12.2 Celgene Corporation Major Business
2.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Product and Services
2.12.4 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Panacea Biotec
2.13.1 Panacea Biotec Details
2.13.2 Panacea Biotec Major Business
2.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Product and Services
2.13.4 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Serum Institute of India
2.14.1 Serum Institute of India Details
2.14.2 Serum Institute of India Major Business
2.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Product and Services
2.14.4 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Genentech
2.15.1 Genentech Details
2.15.2 Genentech Major Business
2.15.3 Genentech Streptococcus Pneumoniae Vaccine Product and Services
2.15.4 Genentech Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Genocea Biosciences
2.16.1 Genocea Biosciences Details
2.16.2 Genocea Biosciences Major Business
2.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product and Services
2.16.4 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 ImmunoBiology
2.17.1 ImmunoBiology Details
2.17.2 ImmunoBiology Major Business
2.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Product and Services
2.17.4 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Lupin
2.18.1 Lupin Details
2.18.2 Lupin Major Business
2.18.3 Lupin Streptococcus Pneumoniae Vaccine Product and Services
2.18.4 Lupin Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Nuron Biotech
2.19.1 Nuron Biotech Details
2.19.2 Nuron Biotech Major Business
2.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Product and Services
2.19.4 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Biogen
2.20.1 Biogen Details
2.20.2 Biogen Major Business
2.20.3 Biogen Streptococcus Pneumoniae Vaccine Product and Services
2.20.4 Biogen Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Valneva Austria
2.21.1 Valneva Austria Details
2.21.2 Valneva Austria Major Business
2.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Product and Services
2.21.4 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Sinovac
2.22.1 Sinovac Details
2.22.2 Sinovac Major Business
2.22.3 Sinovac Streptococcus Pneumoniae Vaccine Product and Services
2.22.4 Sinovac Streptococcus Pneumoniae Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Streptococcus Pneumoniae Vaccine Breakdown Data by Manufacturer
3.1 Global Streptococcus Pneumoniae Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Streptococcus Pneumoniae Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Streptococcus Pneumoniae Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Streptococcus Pneumoniae Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Streptococcus Pneumoniae Vaccine Manufacturer Market Share in 2021
3.5 Global Streptococcus Pneumoniae Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Streptococcus Pneumoniae Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Streptococcus Pneumoniae Vaccine Market Size by Region
4.1.1 Global Streptococcus Pneumoniae Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2028)
4.2 North America Streptococcus Pneumoniae Vaccine Revenue (2017-2028)
4.3 Europe Streptococcus Pneumoniae Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Streptococcus Pneumoniae Vaccine Revenue (2017-2028)
4.5 South America Streptococcus Pneumoniae Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Streptococcus Pneumoniae Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Streptococcus Pneumoniae Vaccine Revenue by Type (2017-2028)
5.3 Global Streptococcus Pneumoniae Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Streptococcus Pneumoniae Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Streptococcus Pneumoniae Vaccine Revenue by Application (2017-2028)
6.3 Global Streptococcus Pneumoniae Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Streptococcus Pneumoniae Vaccine Sales by Type (2017-2028)
7.2 North America Streptococcus Pneumoniae Vaccine Sales by Application (2017-2028)
7.3 North America Streptococcus Pneumoniae Vaccine Market Size by Country
7.3.1 North America Streptococcus Pneumoniae Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Streptococcus Pneumoniae Vaccine Sales by Type (2017-2028)
8.2 Europe Streptococcus Pneumoniae Vaccine Sales by Application (2017-2028)
8.3 Europe Streptococcus Pneumoniae Vaccine Market Size by Country
8.3.1 Europe Streptococcus Pneumoniae Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Streptococcus Pneumoniae Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Streptococcus Pneumoniae Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Streptococcus Pneumoniae Vaccine Market Size by Region
9.3.1 Asia-Pacific Streptococcus Pneumoniae Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Streptococcus Pneumoniae Vaccine Sales by Type (2017-2028)
10.2 South America Streptococcus Pneumoniae Vaccine Sales by Application (2017-2028)
10.3 South America Streptococcus Pneumoniae Vaccine Market Size by Country
10.3.1 South America Streptococcus Pneumoniae Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Streptococcus Pneumoniae Vaccine Market Size by Country
11.3.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Streptococcus Pneumoniae Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Streptococcus Pneumoniae Vaccine
12.3 Streptococcus Pneumoniae Vaccine Production Process
12.4 Streptococcus Pneumoniae Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Streptococcus Pneumoniae Vaccine Typical Distributors
13.3 Streptococcus Pneumoniae Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Streptococcus Pneumoniae Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Streptococcus Pneumoniae Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Streptococcus Pneumoniae Vaccine Product and Services
Table 6. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Streptococcus Pneumoniae Vaccine Product and Services
Table 10. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Streptococcus Pneumoniae Vaccine Product and Services
Table 14. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Streptococcus Pneumoniae Vaccine Product and Services
Table 18. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Streptococcus Pneumoniae Vaccine Product and Services
Table 22. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Streptococcus Pneumoniae Vaccine Product and Services
Table 26. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Abera Basic Information, Manufacturing Base and Competitors
Table 28. Abera Major Business
Table 29. Abera Streptococcus Pneumoniae Vaccine Product and Services
Table 30. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. S K Chemicals Basic Information, Manufacturing Base and Competitors
Table 32. S K Chemicals Major Business
Table 33. S K Chemicals Streptococcus Pneumoniae Vaccine Product and Services
Table 34. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Beijing Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 36. Beijing Minhai Biotechnology Major Business
Table 37. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product and Services
Table 38. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Baxter Basic Information, Manufacturing Base and Competitors
Table 40. Baxter Major Business
Table 41. Baxter Streptococcus Pneumoniae Vaccine Product and Services
Table 42. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Biken Basic Information, Manufacturing Base and Competitors
Table 44. Biken Major Business
Table 45. Biken Streptococcus Pneumoniae Vaccine Product and Services
Table 46. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 48. Celgene Corporation Major Business
Table 49. Celgene Corporation Streptococcus Pneumoniae Vaccine Product and Services
Table 50. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 52. Panacea Biotec Major Business
Table 53. Panacea Biotec Streptococcus Pneumoniae Vaccine Product and Services
Table 54. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 56. Serum Institute of India Major Business
Table 57. Serum Institute of India Streptococcus Pneumoniae Vaccine Product and Services
Table 58. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Genentech Basic Information, Manufacturing Base and Competitors
Table 60. Genentech Major Business
Table 61. Genentech Streptococcus Pneumoniae Vaccine Product and Services
Table 62. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Genocea Biosciences Basic Information, Manufacturing Base and Competitors
Table 64. Genocea Biosciences Major Business
Table 65. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product and Services
Table 66. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. ImmunoBiology Basic Information, Manufacturing Base and Competitors
Table 68. ImmunoBiology Major Business
Table 69. ImmunoBiology Streptococcus Pneumoniae Vaccine Product and Services
Table 70. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Lupin Basic Information, Manufacturing Base and Competitors
Table 72. Lupin Major Business
Table 73. Lupin Streptococcus Pneumoniae Vaccine Product and Services
Table 74. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Nuron Biotech Basic Information, Manufacturing Base and Competitors
Table 76. Nuron Biotech Major Business
Table 77. Nuron Biotech Streptococcus Pneumoniae Vaccine Product and Services
Table 78. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Biogen Basic Information, Manufacturing Base and Competitors
Table 80. Biogen Major Business
Table 81. Biogen Streptococcus Pneumoniae Vaccine Product and Services
Table 82. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Valneva Austria Basic Information, Manufacturing Base and Competitors
Table 84. Valneva Austria Major Business
Table 85. Valneva Austria Streptococcus Pneumoniae Vaccine Product and Services
Table 86. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Sinovac Basic Information, Manufacturing Base and Competitors
Table 88. Sinovac Major Business
Table 89. Sinovac Streptococcus Pneumoniae Vaccine Product and Services
Table 90. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Global Streptococcus Pneumoniae Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 92. Global Streptococcus Pneumoniae Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 93. Market Position of Manufacturers in Streptococcus Pneumoniae Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 94. Global Streptococcus Pneumoniae Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 95. Head Office and Streptococcus Pneumoniae Vaccine Production Site of Key Manufacturer
Table 96. Streptococcus Pneumoniae Vaccine New Entrant and Capacity Expansion Plans
Table 97. Streptococcus Pneumoniae Vaccine Mergers & Acquisitions in the Past Five Years
Table 98. Global Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) & (K Units)
Table 99. Global Streptococcus Pneumoniae Vaccine Sales by Region (2023-2028) & (K Units)
Table 100. Global Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 101. Global Streptococcus Pneumoniae Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 102. Global Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
Table 103. Global Streptococcus Pneumoniae Vaccine Sales by Type (2023-2028) & (K Units)
Table 104. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 105. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 106. Global Streptococcus Pneumoniae Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 107. Global Streptococcus Pneumoniae Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 108. Global Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
Table 109. Global Streptococcus Pneumoniae Vaccine Sales by Application (2023-2028) & (K Units)
Table 110. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 111. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 112. Global Streptococcus Pneumoniae Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 113. Global Streptococcus Pneumoniae Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 114. North America Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
Table 115. North America Streptococcus Pneumoniae Vaccine Sales by Country (2023-2028) & (K Units)
Table 116. North America Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 117. North America Streptococcus Pneumoniae Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 118. North America Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
Table 119. North America Streptococcus Pneumoniae Vaccine Sales by Type (2023-2028) & (K Units)
Table 120. North America Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
Table 121. North America Streptococcus Pneumoniae Vaccine Sales by Application (2023-2028) & (K Units)
Table 122. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
Table 123. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2023-2028) & (K Units)
Table 124. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 125. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 126. Europe Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
Table 127. Europe Streptococcus Pneumoniae Vaccine Sales by Type (2023-2028) & (K Units)
Table 128. Europe Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
Table 129. Europe Streptococcus Pneumoniae Vaccine Sales by Application (2023-2028) & (K Units)
Table 130. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) & (K Units)
Table 131. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales by Region (2023-2028) & (K Units)
Table 132. Asia-Pacific Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 133. Asia-Pacific Streptococcus Pneumoniae Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 134. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
Table 135. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales by Type (2023-2028) & (K Units)
Table 136. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
Table 137. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales by Application (2023-2028) & (K Units)
Table 138. South America Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
Table 139. South America Streptococcus Pneumoniae Vaccine Sales by Country (2023-2028) & (K Units)
Table 140. South America Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 141. South America Streptococcus Pneumoniae Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 142. South America Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
Table 143. South America Streptococcus Pneumoniae Vaccine Sales by Type (2023-2028) & (K Units)
Table 144. South America Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
Table 145. South America Streptococcus Pneumoniae Vaccine Sales by Application (2023-2028) & (K Units)
Table 146. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) & (K Units)
Table 147. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Region (2023-2028) & (K Units)
Table 148. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 149. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 150. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
Table 151. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2023-2028) & (K Units)
Table 152. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)
Table 153. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2023-2028) & (K Units)
Table 154. Streptococcus Pneumoniae Vaccine Raw Material
Table 155. Key Manufacturers of Streptococcus Pneumoniae Vaccine Raw Materials
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Streptococcus Pneumoniae Vaccine Typical Distributors
Table 159. Streptococcus Pneumoniae Vaccine Typical Customers
List of Figures
Figure 1. Streptococcus Pneumoniae Vaccine Picture
Figure 2. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type in 2021
Figure 3. 7 -Valent
Figure 4. 10 -Valent
Figure 5. 13 -Valent
Figure 6. 15 -Valent
Figure 7. 23 -Valent
Figure 8. Other
Figure 9. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application in 2021
Figure 10. Children under 2 Years of Age
Figure 11. Adults over 65 Years of Age
Figure 12. Addicted Smokers Between the Ages of 19 and 64
Figure 13. Other
Figure 14. Global Streptococcus Pneumoniae Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 15. Global Streptococcus Pneumoniae Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Streptococcus Pneumoniae Vaccine Sales (2017-2028) & (K Units)
Figure 17. Global Streptococcus Pneumoniae Vaccine Price (2017-2028) & (US$/Unit)
Figure 18. Global Streptococcus Pneumoniae Vaccine Production Capacity (2017-2028) & (K Units)
Figure 19. Global Streptococcus Pneumoniae Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Streptococcus Pneumoniae Vaccine Market Drivers
Figure 21. Streptococcus Pneumoniae Vaccine Market Restraints
Figure 22. Streptococcus Pneumoniae Vaccine Market Trends
Figure 23. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Manufacturer in 2021
Figure 24. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Manufacturer in 2021
Figure 25. Streptococcus Pneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Streptococcus Pneumoniae Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Streptococcus Pneumoniae Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2028)
Figure 29. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2028)
Figure 30. North America Streptococcus Pneumoniae Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Europe Streptococcus Pneumoniae Vaccine Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Streptococcus Pneumoniae Vaccine Revenue (2017-2028) & (USD Million)
Figure 33. South America Streptococcus Pneumoniae Vaccine Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue (2017-2028) & (USD Million)
Figure 35. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2028)
Figure 36. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2017-2028)
Figure 37. Global Streptococcus Pneumoniae Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 38. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2028)
Figure 39. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2017-2028)
Figure 40. Global Streptococcus Pneumoniae Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 41. North America Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2028)
Figure 42. North America Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2028)
Figure 43. North America Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2028)
Figure 44. North America Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2028)
Figure 45. United States Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2028)
Figure 49. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2028)
Figure 50. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2028)
Figure 51. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2028)
Figure 52. Germany Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2028)
Figure 61. China Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2028)
Figure 68. South America Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2028)
Figure 69. South America Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2028)
Figure 70. South America Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Streptococcus Pneumoniae Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine in 2021
Figure 82. Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
Figure 83. Streptococcus Pneumoniae Vaccine Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
